Patents-Review.com
ClassID:

96984 ⎘

C07K14/57527 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones Calcitonin gene related peptide

Recent Application in this class:
#1
20250154219
2025-05-15

PEPTIDE ANALOGS

 #2
20240418716
2024-12-19

PROTEIN SIGNATURES FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL INFECTIONS

 #3
20230212248
2023-07-06

Use of CGRP receptor antagonists in neuroprotection and neurological disorders

 #4
20220340633
2022-10-27

SUPERAGONIST POLYPEPTIDE ANALOGS OF ADRENOMEDULLIN AND INTERMEDIN PEPTIDE HORMONES

 #5
20220324935
2022-10-13

Peptide analogs

 #6
20220011320
2022-01-13

Protein signatures for distinguishing between bacterial and viral infections

 #7
20210332335
2021-10-28

In vivo protein N-acylation

 #8
20200353088
2020-11-12

PEPTIDE CONJUGATE CGRP RECEPTOR ANTAGONISTS AND METHODS OF PREPARATION AND USES THEREOF

 #9
20200339649
2020-10-29

Peptide analogs

 #10
20200063111
2020-02-27

In vivo protein N-acylation

 #11
20200024320
2020-01-23

Variants of adrenomedullin and calcitonin gene-related peptide and methods of use

 #12
20190120837
2019-04-25

Protein signatures for distinguishing between bacterial and viral infections

 #13
20190010203
2019-01-10

Superagonist polypeptide analogs of adrenomedullin and intermedin peptide hormones

 #14
20180258164
2018-09-13

Biomarkers related to interleukin-33 (IL-33)-mediated diseases and uses thereof

 #15
20180141989
2018-05-24

Variants of adrenomedullin and calcitonin gene-related peptide and methods of use

 #16
20170204155
2017-07-20

Peptide antagonists of the calcitonin CGRP family of peptide hormones and their use

 #17
20170096483
2017-04-06

Biomarkers related to interleukin-33 (IL-33)-mediated diseases and uses thereof

 #18
20160347810
2016-12-01

Compositions and methods for treating acute and chronic pain by local antagonism of CGRP receptors, or combination with sodium channel inhibition or with anti-inflammatory agents

 #19
20160207975
2016-07-21

CGRP agonist peptides

 #20
20160145315
2016-05-26

PEPTIDE ANTAGONISTS OF THE CALCITONIN CGRP FAMILY OF PEPTIDE HORMONES AND THEIR USE

 #21
20150018665
2015-01-15

MOLECULAR AND CELLULAR IMAGING USING ENGINEERED HEMODYNAMIC RESPONSES

 #22
20140329752
2014-11-06

Peptide antagonists of the calcitonin CGRP family of peptide hormones and their use

 #23
20140018286
2014-01-16

Amylin analogues and pharmaceutical compositions thereof

 #24
20140017808
2014-01-16

Prognosis and risk assessment in stroke patients by determining the level of marker peptides

 #25
20130071431
2013-03-21

Method for Preserving Polypeptides Using A Sugar and Polyethyleneimine

 #26
20130059770
2013-03-07

Amylin analogues and pharmaceutical compositions thereof

 #27
20130012427
2013-01-10

Polypeptides

 #28
20130005646
2013-01-03

Polypeptides

 #29
20120245083
2012-09-27

Derivatives of CGRP

 #30
20120058950
2012-03-08

DETECTION OF NEUROPEPTIDES ASSOCIATED WITH PELVIC PAIN DISORDERS AND USES THEREOF

 #31
20110305711
2011-12-15

CGRP antibodies

 #32
20110263821
2011-10-27

PROGNOSIS AND RISK ASSESSMENT IN STROKE PATIENTS BY DETERMINING THE LEVEL OF MARKER PEPTIDES

 #33
20110212127
2011-09-01

Method for Preserving Polypeptides Using a Sugar and Polyethyleneimine

 #34
20110150980
2011-06-23

CGRP ANALOG

 #35
20100284977
2010-11-11

Expression of Anti-Nociceptive Compounds from Endogenously Regulated Promoters

 #36
20080070239
2008-03-20

Detection of neureopeptides associated with pelvic pain disorders and uses thereof

 #37
20080020978
2008-01-24

CGRP peptide antagonists and conjugates

 #38
20060099150
2006-05-11

Compositions and methods for the transport of biologically active agents across cellular barriers